Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1336 CNY

100%

CVE-2021-44464— Fresenius Kabi Agilia Connect Infusion System hard coded credentials

Quick assessment

Affected
Fresenius Kabi Vigilant Software Suite (Mastermed Dashboard)
Exploitation
No confirmed in-the-wild exploitation; assess based on exposure
Recommended action
Check the vendor advisory and references for a fixed version. If immediate upgrade is impossible, restrict exposure and increase monitoring.

Fresenius Kabi Agilia Connect Infusion System是德国Fresenius Kabi公司的一个输液系统。 Fresenius Kabi Agilia Connect Infusion System 存在信任管理问题漏洞,该漏洞源于Vigilant MasterMed应用程序包含可能在所有实例中通用的服务凭据。拥有密码的攻击者可利用该漏洞可以获得该软件所有安装的特权。

CVSS 6.3 · Medium EPSS 0.64% · P48

Possible ATT&CK Techniques 1 AI

T1078 · Valid Accounts
Get alerts for future matching vulnerabilities Log in to subscribe

I. Basic Information for CVE-2021-44464

Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
Fresenius Kabi Agilia Connect Infusion System hard coded credentials
Source: CVE Program / CVE List V5
Vulnerability Description
Vigilant Software Suite (Mastermed Dashboard) version 2.0.1.3 contains service credentials likely to be common across all instances. An attacker in possession of the password may gain privileges on all installations of this software.
Source: CVE Program / CVE List V5
CVSS Information
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
Source: CVE Program / CVE List V5
Vulnerability Type
使用硬编码的凭证
Source: CVE Program / CVE List V5
Vulnerability Title
Fresenius Kabi Agilia Connect Infusion System 信任管理问题漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Fresenius Kabi Agilia Connect Infusion System是德国Fresenius Kabi公司的一个输液系统。 Fresenius Kabi Agilia Connect Infusion System 存在信任管理问题漏洞,该漏洞源于Vigilant MasterMed应用程序包含可能在所有实例中通用的服务凭据。拥有密码的攻击者可利用该漏洞可以获得该软件所有安装的特权。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)

Affected Products

Vendor Product Affected Versions CPE Subscribe
Fresenius Kabi Vigilant Software Suite (Mastermed Dashboard) unspecified ~ 2.0.1.3 -

II. Public POCs for CVE-2021-44464

# POC Description Source Link Shenlong Link
AI-Generated POC Premium

No public POC found.

Login to generate AI POC

III. Intelligence Information for CVE-2021-44464

登录查看更多情报信息。

Vendor Advisories for CVE-2021-44464 (1)

Same Patch Batch · Fresenius Kabi · 2022-01-21 · 12 CVEs total

CVE-2021-23236 7.5 HIGH Fresenius Kabi Agilia Connect Infusion System uncontrolled resource consumption
CVE-2021-23196 7.3 HIGH Fresenius Kabi Agilia Connect Infusion System insufficiently protected credentials
CVE-2021-23233 7.3 HIGH Fresenius Kabi Agilia Connect Infusion System
CVE-2021-41835 7.3 HIGH Fresenius Kabi Agilia Connect Infusion System use of a broken or risky cryptographic algor
CVE-2021-43355 7.3 HIGH Fresenius Kabi Agilia Connect Infusion System use of client side authentication
CVE-2021-23207 6.5 MEDIUM Fresenius Kabi Agilia Connect Infusion System plaintext storage of a password
CVE-2021-31562 6.5 MEDIUM Fresenius Kabi Agilia Connect Infusion System use of a broken or risky cryptographic algor
CVE-2021-33846 5.9 MEDIUM Fresenius Kabi Agilia Connect Infusion System use of a broken or risky cryptographic algor
CVE-2021-33848 5.4 MEDIUM Fresenius Kabi Agilia Connect Infusion System cross site scripting
CVE-2021-23195 5.3 MEDIUM Fresenius Kabi Agilia Connect Infusion System exposure of information through directory li
CVE-2021-33843 5.3 MEDIUM Fresenius Kabi Agilia Connect Infusion System files or directories accessible to external

IV. Related Vulnerabilities

V. Comments for CVE-2021-44464

No comments yet


Leave a comment